Applied Radiation Oncology

The physical and biological underpinnings of HPT, especially its ability to target CSCs via high LET-induced damage, provide a compelling foundation for its clinical application in aggressive and treatment-resistant tumors. 🔗 ow.ly/LR1f30sOck7 #RadOnc #RadOncEd

Data to guide treatment recommendations are lacking our case highlights the need for further research to improve understanding of develop data-driven treatment recommendations for and improve longterm patient outcomes in this rare malignancy 🔗 ow.ly/uqHy30sOckc #RadOncEd

Do all residents feel equally prepared for independent practice at the time of graduation? 🔗 ow.ly/UGRK30sOcke #RadOnc #RadOncEd

By redefining how we train the next generation of radiation oncologists and by refining our approach to radioresistant tumors, each article invites us to reconsider established paradigms and embrace innovation @DrJohnSuh 🔗 ow.ly/62sW30sOcka #RadOnc #RadOncEd

Curious to hear about the experience of one radiation oncology residency applicant? Check out our interview with @RadQian ➡️ bit.ly/4coi9jo #RadOnc #RadOncResident #RadOncResidency #Resident

"The difficulty we face with sarcoma is that the data are inherently dirty. It’s hard to get enough numbers – especially for individual histologies," @DrKyraWrites ow.ly/w9T530sNIYv #SarcomaAwarenessMonth #SarcomaAwareness #RadOnc

PTX and VE are safe interventions that may prophylactically reduce rates of grade 3 pneumonitis for patients receiving subsequent SABR for recurrent NSCLC. ow.ly/1Tmc30sOck9 #RadOnc #RadOncEd

Economic and logistical challenges to expanding the reach of HPT are real but not insuperable, and the reduction it could entail in terms of reduced cancer recurrences may yield reductions in overall health care costs in the long run 🔗 ow.ly/xGo930sOck8 #RadOnc #RadOncEd

Jessica Aduwo & Sohil Reddy meet with the Vice Chair and Medical Director of the Department of Rad Onc at the Miami Cancer Institute, Dr. Michael Chuong, to discuss the role of radiation therapy for locally advanced pancreatic cancer treatment. 🔗 bit.ly/3IAEnFs

Disease Characteristics, Treatment Tolerance, and Toxicity in Older Patients (≥ 65 y) With Oropharyngeal Cancer and Implications on Outcomes 🔗 bit.ly/4kM6M8W #RadOnc #RadOncEd

New issue alert! 🔗 bit.ly/3GDsU7z 🎓 CME Article ☢️ Review Articles 🩻 Case Report 🖋️ New Editorial from John H. Suh MD #RadOnc #RadOncEd #RadiationOncology #MedEd #CME

Want to hear more from radiation oncologist Charles Thomas, MD? Check out the full interview in RadOnc Student Scan Issue 8 ➡️ bit.ly/3Yyl70V #RadOnc #RadiationOncologist

"Deep learning has shown remarkable promise in various medical fields, and its application in STSs is no exception,” shares Zhihong Li, senior and co-corresponding author of the study. ow.ly/s5IG30sNIYu #SarcomaAwarenessMonth #SarcomaAwareness #RadOnc

CME Opportunity! 🔗 bit.ly/4nS5hcg This review article describes technical advantages for MR guided radiation therapy (MRgRT) that lead to the rationale for use in the oligometastatic setting. #RadEd #MedEd #CME

National Trends in External-Beam Radiation Therapy for Brain Metastases from Lung, Breast & Melanoma Cancers 🔗 bit.ly/3GKhKxG RT in the form of SRS or WBRT is fundamental for managing BM. We analyzed national trends in RT and BM patient survival between 2010 and 2019

A Rare Case of Skull Base Phosphaturic Mesenchymal Tumor 🔗 bit.ly/4nMnPu8 The most common sites of PMT involvement are extremities. Here, we report a rare case of PMT involving the skull base. #RadOnc #RadOncEd #MedEd

Battling Bunk: Cancer Misinformation’s Impact on Patients and How Providers Can Respond 🔗 bit.ly/469e4js #RadOnc #HealthcareMisinformation #CancerCare

High-Resolution Mammography Improves Breast Cancer Detection, Especially With Prior Imaging 🔗 bit.ly/4kA88DL “With the introduction of any new breast screening technology, it is important to evaluate the impact on real world clinical outcomes,” said Melinda Talley, MD

🎙️ Have you listened yet? 🔗 bit.ly/4nB008O @JKMatsui a 4th-year medical student at Ohio State, and Memorial Sloan Kettering’s @KaitlynLapen discuss confusion and solutions surrounding SBRT vs SABR terminology and its impact on metastatic cancer treatment decisions.

Rural Patients Less Likely to Receive Advanced PET Imaging for #ProstateCancer National Study Finds 🔗 bit.ly/4eGzxCo “While we’ve long recognized racial disparities in prostate cancer care this analysis shows that rurality compounds those inequities,” said the authors